img

Global Pharma 4.0 Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Pharma 4.0 Market Research Report 2024

Pharma 4.0 is a holistic operating model for pharmaceutical factories and supply chains of the future based on Industry 4.0 capabilities, digital maturity, and data integrity by design.Pharma 4.0 is a framework for adapting digital strategies to the unique contexts of pharmaceutical manufacturing. In practical terms, it means more connectivity, more productivity, simplified compliance, and the marshaling of production information to respond to problems as they emerge.
According to Mr Accuracy reports new survey, global Pharma 4.0 market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pharma 4.0 market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pharma 4.0 market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Pfizer Inc
Abbott Laboratories
GE Healthcare
Boston Scientific
Medtronic Plc.
Lonza Group AG
GlaxoSmithKline plc.
Koninklijke Philips N.V.
Glatt GmbH
Vertex
Johnson & Johnson
Goodly Innovations
QbDVision
Electrosan
GoSilico
Smart Factory
Körber AG
Segment by Type
Cloud
On-premise

Segment by Application


Pharmaceutical Industry
IoT Industry
Medical Equipment Industry
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Pharma 4.0 report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharma 4.0 Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Cloud
1.2.3 On-premise
1.3 Market by Application
1.3.1 Global Pharma 4.0 Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical Industry
1.3.3 IoT Industry
1.3.4 Medical Equipment Industry
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharma 4.0 Market Perspective (2018-2029)
2.2 Pharma 4.0 Growth Trends by Region
2.2.1 Global Pharma 4.0 Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Pharma 4.0 Historic Market Size by Region (2018-2024)
2.2.3 Pharma 4.0 Forecasted Market Size by Region (2024-2029)
2.3 Pharma 4.0 Market Dynamics
2.3.1 Pharma 4.0 Industry Trends
2.3.2 Pharma 4.0 Market Drivers
2.3.3 Pharma 4.0 Market Challenges
2.3.4 Pharma 4.0 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharma 4.0 Players by Revenue
3.1.1 Global Top Pharma 4.0 Players by Revenue (2018-2024)
3.1.2 Global Pharma 4.0 Revenue Market Share by Players (2018-2024)
3.2 Global Pharma 4.0 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharma 4.0 Revenue
3.4 Global Pharma 4.0 Market Concentration Ratio
3.4.1 Global Pharma 4.0 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharma 4.0 Revenue in 2022
3.5 Pharma 4.0 Key Players Head office and Area Served
3.6 Key Players Pharma 4.0 Product Solution and Service
3.7 Date of Enter into Pharma 4.0 Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharma 4.0 Breakdown Data by Type
4.1 Global Pharma 4.0 Historic Market Size by Type (2018-2024)
4.2 Global Pharma 4.0 Forecasted Market Size by Type (2024-2029)
5 Pharma 4.0 Breakdown Data by Application
5.1 Global Pharma 4.0 Historic Market Size by Application (2018-2024)
5.2 Global Pharma 4.0 Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Pharma 4.0 Market Size (2018-2029)
6.2 North America Pharma 4.0 Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Pharma 4.0 Market Size by Country (2018-2024)
6.4 North America Pharma 4.0 Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharma 4.0 Market Size (2018-2029)
7.2 Europe Pharma 4.0 Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Pharma 4.0 Market Size by Country (2018-2024)
7.4 Europe Pharma 4.0 Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharma 4.0 Market Size (2018-2029)
8.2 Asia-Pacific Pharma 4.0 Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Pharma 4.0 Market Size by Region (2018-2024)
8.4 Asia-Pacific Pharma 4.0 Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharma 4.0 Market Size (2018-2029)
9.2 Latin America Pharma 4.0 Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Pharma 4.0 Market Size by Country (2018-2024)
9.4 Latin America Pharma 4.0 Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharma 4.0 Market Size (2018-2029)
10.2 Middle East & Africa Pharma 4.0 Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Pharma 4.0 Market Size by Country (2018-2024)
10.4 Middle East & Africa Pharma 4.0 Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer Inc
11.1.1 Pfizer Inc Company Detail
11.1.2 Pfizer Inc Business Overview
11.1.3 Pfizer Inc Pharma 4.0 Introduction
11.1.4 Pfizer Inc Revenue in Pharma 4.0 Business (2018-2024)
11.1.5 Pfizer Inc Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Detail
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Pharma 4.0 Introduction
11.2.4 Abbott Laboratories Revenue in Pharma 4.0 Business (2018-2024)
11.2.5 Abbott Laboratories Recent Development
11.3 GE Healthcare
11.3.1 GE Healthcare Company Detail
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare Pharma 4.0 Introduction
11.3.4 GE Healthcare Revenue in Pharma 4.0 Business (2018-2024)
11.3.5 GE Healthcare Recent Development
11.4 Boston Scientific
11.4.1 Boston Scientific Company Detail
11.4.2 Boston Scientific Business Overview
11.4.3 Boston Scientific Pharma 4.0 Introduction
11.4.4 Boston Scientific Revenue in Pharma 4.0 Business (2018-2024)
11.4.5 Boston Scientific Recent Development
11.5 Medtronic Plc.
11.5.1 Medtronic Plc. Company Detail
11.5.2 Medtronic Plc. Business Overview
11.5.3 Medtronic Plc. Pharma 4.0 Introduction
11.5.4 Medtronic Plc. Revenue in Pharma 4.0 Business (2018-2024)
11.5.5 Medtronic Plc. Recent Development
11.6 Lonza Group AG
11.6.1 Lonza Group AG Company Detail
11.6.2 Lonza Group AG Business Overview
11.6.3 Lonza Group AG Pharma 4.0 Introduction
11.6.4 Lonza Group AG Revenue in Pharma 4.0 Business (2018-2024)
11.6.5 Lonza Group AG Recent Development
11.7 GlaxoSmithKline plc.
11.7.1 GlaxoSmithKline plc. Company Detail
11.7.2 GlaxoSmithKline plc. Business Overview
11.7.3 GlaxoSmithKline plc. Pharma 4.0 Introduction
11.7.4 GlaxoSmithKline plc. Revenue in Pharma 4.0 Business (2018-2024)
11.7.5 GlaxoSmithKline plc. Recent Development
11.8 Koninklijke Philips N.V.
11.8.1 Koninklijke Philips N.V. Company Detail
11.8.2 Koninklijke Philips N.V. Business Overview
11.8.3 Koninklijke Philips N.V. Pharma 4.0 Introduction
11.8.4 Koninklijke Philips N.V. Revenue in Pharma 4.0 Business (2018-2024)
11.8.5 Koninklijke Philips N.V. Recent Development
11.9 Glatt GmbH
11.9.1 Glatt GmbH Company Detail
11.9.2 Glatt GmbH Business Overview
11.9.3 Glatt GmbH Pharma 4.0 Introduction
11.9.4 Glatt GmbH Revenue in Pharma 4.0 Business (2018-2024)
11.9.5 Glatt GmbH Recent Development
11.10 Vertex
11.10.1 Vertex Company Detail
11.10.2 Vertex Business Overview
11.10.3 Vertex Pharma 4.0 Introduction
11.10.4 Vertex Revenue in Pharma 4.0 Business (2018-2024)
11.10.5 Vertex Recent Development
11.11 Johnson & Johnson
11.11.1 Johnson & Johnson Company Detail
11.11.2 Johnson & Johnson Business Overview
11.11.3 Johnson & Johnson Pharma 4.0 Introduction
11.11.4 Johnson & Johnson Revenue in Pharma 4.0 Business (2018-2024)
11.11.5 Johnson & Johnson Recent Development
11.12 Goodly Innovations
11.12.1 Goodly Innovations Company Detail
11.12.2 Goodly Innovations Business Overview
11.12.3 Goodly Innovations Pharma 4.0 Introduction
11.12.4 Goodly Innovations Revenue in Pharma 4.0 Business (2018-2024)
11.12.5 Goodly Innovations Recent Development
11.13 QbDVision
11.13.1 QbDVision Company Detail
11.13.2 QbDVision Business Overview
11.13.3 QbDVision Pharma 4.0 Introduction
11.13.4 QbDVision Revenue in Pharma 4.0 Business (2018-2024)
11.13.5 QbDVision Recent Development
11.14 Electrosan
11.14.1 Electrosan Company Detail
11.14.2 Electrosan Business Overview
11.14.3 Electrosan Pharma 4.0 Introduction
11.14.4 Electrosan Revenue in Pharma 4.0 Business (2018-2024)
11.14.5 Electrosan Recent Development
11.15 GoSilico
11.15.1 GoSilico Company Detail
11.15.2 GoSilico Business Overview
11.15.3 GoSilico Pharma 4.0 Introduction
11.15.4 GoSilico Revenue in Pharma 4.0 Business (2018-2024)
11.15.5 GoSilico Recent Development
11.16 Smart Factory
11.16.1 Smart Factory Company Detail
11.16.2 Smart Factory Business Overview
11.16.3 Smart Factory Pharma 4.0 Introduction
11.16.4 Smart Factory Revenue in Pharma 4.0 Business (2018-2024)
11.16.5 Smart Factory Recent Development
11.17 Körber AG
11.17.1 Körber AG Company Detail
11.17.2 Körber AG Business Overview
11.17.3 Körber AG Pharma 4.0 Introduction
11.17.4 Körber AG Revenue in Pharma 4.0 Business (2018-2024)
11.17.5 Körber AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Pharma 4.0 Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Cloud
Table 3. Key Players of On-premise
Table 4. Global Pharma 4.0 Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Pharma 4.0 Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Pharma 4.0 Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Pharma 4.0 Market Share by Region (2018-2024)
Table 8. Global Pharma 4.0 Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Pharma 4.0 Market Share by Region (2024-2029)
Table 10. Pharma 4.0 Market Trends
Table 11. Pharma 4.0 Market Drivers
Table 12. Pharma 4.0 Market Challenges
Table 13. Pharma 4.0 Market Restraints
Table 14. Global Pharma 4.0 Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Pharma 4.0 Market Share by Players (2018-2024)
Table 16. Global Top Pharma 4.0 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma 4.0 as of 2022)
Table 17. Ranking of Global Top Pharma 4.0 Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Pharma 4.0 Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Pharma 4.0 Product Solution and Service
Table 21. Date of Enter into Pharma 4.0 Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Pharma 4.0 Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Pharma 4.0 Revenue Market Share by Type (2018-2024)
Table 25. Global Pharma 4.0 Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Pharma 4.0 Revenue Market Share by Type (2024-2029)
Table 27. Global Pharma 4.0 Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Pharma 4.0 Revenue Market Share by Application (2018-2024)
Table 29. Global Pharma 4.0 Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Pharma 4.0 Revenue Market Share by Application (2024-2029)
Table 31. North America Pharma 4.0 Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Pharma 4.0 Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America Pharma 4.0 Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Pharma 4.0 Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Pharma 4.0 Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe Pharma 4.0 Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Pharma 4.0 Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Pharma 4.0 Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific Pharma 4.0 Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Pharma 4.0 Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Pharma 4.0 Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America Pharma 4.0 Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Pharma 4.0 Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Pharma 4.0 Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa Pharma 4.0 Market Size by Country (2024-2029) & (US$ Million)
Table 46. Pfizer Inc Company Detail
Table 47. Pfizer Inc Business Overview
Table 48. Pfizer Inc Pharma 4.0 Product
Table 49. Pfizer Inc Revenue in Pharma 4.0 Business (2018-2024) & (US$ Million)
Table 50. Pfizer Inc Recent Development
Table 51. Abbott Laboratories Company Detail
Table 52. Abbott Laboratories Business Overview
Table 53. Abbott Laboratories Pharma 4.0 Product
Table 54. Abbott Laboratories Revenue in Pharma 4.0 Business (2018-2024) & (US$ Million)
Table 55. Abbott Laboratories Recent Development
Table 56. GE Healthcare Company Detail
Table 57. GE Healthcare Business Overview
Table 58. GE Healthcare Pharma 4.0 Product
Table 59. GE Healthcare Revenue in Pharma 4.0 Business (2018-2024) & (US$ Million)
Table 60. GE Healthcare Recent Development
Table 61. Boston Scientific Company Detail
Table 62. Boston Scientific Business Overview
Table 63. Boston Scientific Pharma 4.0 Product
Table 64. Boston Scientific Revenue in Pharma 4.0 Business (2018-2024) & (US$ Million)
Table 65. Boston Scientific Recent Development
Table 66. Medtronic Plc. Company Detail
Table 67. Medtronic Plc. Business Overview
Table 68. Medtronic Plc. Pharma 4.0 Product
Table 69. Medtronic Plc. Revenue in Pharma 4.0 Business (2018-2024) & (US$ Million)
Table 70. Medtronic Plc. Recent Development
Table 71. Lonza Group AG Company Detail
Table 72. Lonza Group AG Business Overview
Table 73. Lonza Group AG Pharma 4.0 Product
Table 74. Lonza Group AG Revenue in Pharma 4.0 Business (2018-2024) & (US$ Million)
Table 75. Lonza Group AG Recent Development
Table 76. GlaxoSmithKline plc. Company Detail
Table 77. GlaxoSmithKline plc. Business Overview
Table 78. GlaxoSmithKline plc. Pharma 4.0 Product
Table 79. GlaxoSmithKline plc. Revenue in Pharma 4.0 Business (2018-2024) & (US$ Million)
Table 80. GlaxoSmithKline plc. Recent Development
Table 81. Koninklijke Philips N.V. Company Detail
Table 82. Koninklijke Philips N.V. Business Overview
Table 83. Koninklijke Philips N.V. Pharma 4.0 Product
Table 84. Koninklijke Philips N.V. Revenue in Pharma 4.0 Business (2018-2024) & (US$ Million)
Table 85. Koninklijke Philips N.V. Recent Development
Table 86. Glatt GmbH Company Detail
Table 87. Glatt GmbH Business Overview
Table 88. Glatt GmbH Pharma 4.0 Product
Table 89. Glatt GmbH Revenue in Pharma 4.0 Business (2018-2024) & (US$ Million)
Table 90. Glatt GmbH Recent Development
Table 91. Vertex Company Detail
Table 92. Vertex Business Overview
Table 93. Vertex Pharma 4.0 Product
Table 94. Vertex Revenue in Pharma 4.0 Business (2018-2024) & (US$ Million)
Table 95. Vertex Recent Development
Table 96. Johnson & Johnson Company Detail
Table 97. Johnson & Johnson Business Overview
Table 98. Johnson & Johnson Pharma 4.0 Product
Table 99. Johnson & Johnson Revenue in Pharma 4.0 Business (2018-2024) & (US$ Million)
Table 100. Johnson & Johnson Recent Development
Table 101. Goodly Innovations Company Detail
Table 102. Goodly Innovations Business Overview
Table 103. Goodly Innovations Pharma 4.0 Product
Table 104. Goodly Innovations Revenue in Pharma 4.0 Business (2018-2024) & (US$ Million)
Table 105. Goodly Innovations Recent Development
Table 106. QbDVision Company Detail
Table 107. QbDVision Business Overview
Table 108. QbDVision Pharma 4.0 Product
Table 109. QbDVision Revenue in Pharma 4.0 Business (2018-2024) & (US$ Million)
Table 110. QbDVision Recent Development
Table 111. Electrosan Company Detail
Table 112. Electrosan Business Overview
Table 113. Electrosan Pharma 4.0 Product
Table 114. Electrosan Revenue in Pharma 4.0 Business (2018-2024) & (US$ Million)
Table 115. Electrosan Recent Development
Table 116. GoSilico Company Detail
Table 117. GoSilico Business Overview
Table 118. GoSilico Pharma 4.0 Product
Table 119. GoSilico Revenue in Pharma 4.0 Business (2018-2024) & (US$ Million)
Table 120. GoSilico Recent Development
Table 121. Smart Factory Company Detail
Table 122. Smart Factory Business Overview
Table 123. Smart Factory Pharma 4.0 Product
Table 124. Smart Factory Revenue in Pharma 4.0 Business (2018-2024) & (US$ Million)
Table 125. Smart Factory Recent Development
Table 126. Körber AG Company Detail
Table 127. Körber AG Business Overview
Table 128. Körber AG Pharma 4.0 Product
Table 129. Körber AG Revenue in Pharma 4.0 Business (2018-2024) & (US$ Million)
Table 130. Körber AG Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharma 4.0 Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Pharma 4.0 Market Share by Type: 2022 VS 2029
Figure 3. Cloud Features
Figure 4. On-premise Features
Figure 5. Global Pharma 4.0 Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 6. Global Pharma 4.0 Market Share by Application: 2022 VS 2029
Figure 7. Pharmaceutical Industry Case Studies
Figure 8. IoT Industry Case Studies
Figure 9. Medical Equipment Industry Case Studies
Figure 10. Others Case Studies
Figure 11. Pharma 4.0 Report Years Considered
Figure 12. Global Pharma 4.0 Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Pharma 4.0 Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Pharma 4.0 Market Share by Region: 2022 VS 2029
Figure 15. Global Pharma 4.0 Market Share by Players in 2022
Figure 16. Global Top Pharma 4.0 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma 4.0 as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Pharma 4.0 Revenue in 2022
Figure 18. North America Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Pharma 4.0 Market Share by Country (2018-2029)
Figure 20. United States Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Pharma 4.0 Market Share by Country (2018-2029)
Figure 24. Germany Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Pharma 4.0 Market Share by Region (2018-2029)
Figure 32. China Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Pharma 4.0 Market Share by Country (2018-2029)
Figure 40. Mexico Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Pharma 4.0 Market Share by Country (2018-2029)
Figure 44. Turkey Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Pharma 4.0 Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Pfizer Inc Revenue Growth Rate in Pharma 4.0 Business (2018-2024)
Figure 47. Abbott Laboratories Revenue Growth Rate in Pharma 4.0 Business (2018-2024)
Figure 48. GE Healthcare Revenue Growth Rate in Pharma 4.0 Business (2018-2024)
Figure 49. Boston Scientific Revenue Growth Rate in Pharma 4.0 Business (2018-2024)
Figure 50. Medtronic Plc. Revenue Growth Rate in Pharma 4.0 Business (2018-2024)
Figure 51. Lonza Group AG Revenue Growth Rate in Pharma 4.0 Business (2018-2024)
Figure 52. GlaxoSmithKline plc. Revenue Growth Rate in Pharma 4.0 Business (2018-2024)
Figure 53. Koninklijke Philips N.V. Revenue Growth Rate in Pharma 4.0 Business (2018-2024)
Figure 54. Glatt GmbH Revenue Growth Rate in Pharma 4.0 Business (2018-2024)
Figure 55. Vertex Revenue Growth Rate in Pharma 4.0 Business (2018-2024)
Figure 56. Johnson & Johnson Revenue Growth Rate in Pharma 4.0 Business (2018-2024)
Figure 57. Goodly Innovations Revenue Growth Rate in Pharma 4.0 Business (2018-2024)
Figure 58. QbDVision Revenue Growth Rate in Pharma 4.0 Business (2018-2024)
Figure 59. Electrosan Revenue Growth Rate in Pharma 4.0 Business (2018-2024)
Figure 60. GoSilico Revenue Growth Rate in Pharma 4.0 Business (2018-2024)
Figure 61. Smart Factory Revenue Growth Rate in Pharma 4.0 Business (2018-2024)
Figure 62. Körber AG Revenue Growth Rate in Pharma 4.0 Business (2018-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries